Disclosure Of Cash Flow Statement [Text Block]

ABIONYX Pharma - Filing #2816648

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
As at
2020-12-31
As at
2020-01-01
Disclosure of cash flow statement [text block]
Cash and cash equivalents in subsidiary or businesses acquired or disposed
1 501 EUR
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
7 935 EUR
9 154 EUR
Cash and cash equivalents if different from statement of financial position
7 772 EUR
9 154 EUR
9 154 EUR
8 331 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.